Pro-Con (Dr. Heier IST study)

Status: Not Enrolling

ClinicalTrials.gov Identifier: NCT02462889

Pro-Con: A Prospective, Single-blind, Randomized Study to Evaluate Intravitreal Aflibercept Injection (IAI) versus Sham as PROphylaxis against CONversion to Neovascular Age-related Macular Degeneration (AMD) in High-Risk Eyes

Condition: AMD

Study Type: Interventional

Duration: 24 months

Eligibility:

  • Ages: Child, Adult, Senior
  • Sexes: All
  • Accepts Healthy Volunteers: No

For additional information, please click here

Go Back
This entry was posted in Uncategorized. Bookmark the permalink.